Ligand validation:5QD2

E6J: (4S)-4-[(1R)-1-hydroxy-2-({[3-(propan-2-yl)phenyl]methyl}amino)ethyl]-19-(methoxymethyl)-11,16-dioxa-3-azatricyclo[15.3.1.1~6,10~]docosa-1(21),6(22),7,9,17,19-hexaen-2-one

E6J is a Ligand Of Interest in 5QD2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5QD2_E6J_C_401	70%	71%	0.155	0.973	0.36	0.74	-	1	0	0	100%	0.9625
5QD2_E6J_B_401	64%	71%	0.165	0.963	0.33	0.78	-	1	0	0	100%	0.975
5QD2_E6J_A_401	59%	74%	0.178	0.96	0.39	0.62	-	1	0	0	100%	0.975

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.